External resources
Current NHS consultant posts held
Daisy Hill Hospital, Newry
Research interests
Inflammatory bowel disease (IBD)
Personal interests
Cycling; triathlons
Awards received
2017 Fellowship of American Gastroenterological Association (AGAF)
2006 FDHN AGA-Centocor International Research Fellowship Award in Gastrointestinal Inflammation and Immunology
2005 BUPA Epidemiology Award for Excellence in the Epidemiological study of Human Diseases
Publications
Selected Publications
Murphy SJ, Kornbluth A. Double balloon enteroscopy in Crohn’s disease: Where Are We Now and Where Should We Go? Inflamm Bowel Dis 2011;17(1):485-90.
Murphy SJ, Ullman TA, Abreu MT. Gut microbes in Crohn’s disease: Getting to know you better? Am J Gastroenterol 2008;103(2):397-8.
Anderson LA, Murray LJ, Murphy SJ, et al. Mortality in Barrett’s oesophagus: results from a population based study. Gut 2003;52(8):1081-4.
Murphy SJ, Dickey W, Hughes D, O’Connor FA. Surveillance for Barrett’s Oesophagus: Results from a programme in Northern Ireland. Eur J Gastroenterol Hepatol 2005;17(10):1029-35.
Murphy SJ, Anderson LA, Mainie I, et al. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus. Scand J Gastroenterol 2005; 40(12):1449-53.
Murphy SJ, Johnston BT, Murray LJ. British Society of Gastroenterology guidelines for the diagnosis of Barrett’s oesophagus – are we casting the net too wide? Gut 2006; 55 (12):1821-2.
Anderson LA, Watson RGP, Murphy SJ, et al. Risk factors for oesophageal adenocarcinoma and Barrett's esophagus – results from the FINBAR study. World J Gastroenterol 2007;13(10):1585-94.
Murphy SJ, Hughes AE, Patterson CC, et al. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett’s esophagus and esophageal adenocarcinoma Carcinogenesis 2007;28(6):1323-8.
Sternthal MB, Murphy SJ, George J, et al. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103(4):937-43.
Reddy D, Murphy SJ, Kane SV, et al. Relapses of inflammatory bowel disease during pregnancy: In-hospital management and birth outcomes. Am J Gastroenterol 2008;103(5):1203-9.
Murphy SJ, Wang L, Anderson LA, et al. Withdrawal of corticosteroids in patients with inflammatory bowel disease after dependency periods ranging from 2 to 45 years: A proposed method. Aliment Pharmacol Ther 2009;30(10):1078-86.
Murphy SJ, Mayer L, Abreu MT. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a Patient with Aspirin Hypersensitivity and Ulcerative Colitis. J Clin Gastro 2011;45(1):83-4.
McDermott E, Murphy S, Keegan D, et al. Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis. J Crohns Colitis. 2012 Apr 18. [Epub ahead of print].
Courses offered to GPs
I give talks to GPs in the locality relating to any gastroenterology or general liver topic of interest
